These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6717 related articles for article (PubMed ID: 2692570)

  • 21. Recombinant interleukin-18 protects against disseminated Candida albicans infection in mice.
    Stuyt RJ; Netea MG; van Krieken JH; van der Meer JW; Kullberg BJ
    J Infect Dis; 2004 Apr; 189(8):1524-7. PubMed ID: 15073691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of graft-versus-leukemia (GVL) activity in murine leukemia models after IL-2 pretreatment of syngeneic and allogeneic bone marrow grafts.
    Zeis M; Uharek L; Glass B; Gaska T; Gassmann W; Mueller-Ruchholtz W
    Bone Marrow Transplant; 1994 Nov; 14(5):711-5. PubMed ID: 7889004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice.
    Huang W; Na L; Fidel PL; Schwarzenberger P
    J Infect Dis; 2004 Aug; 190(3):624-31. PubMed ID: 15243941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD4+ subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance.
    Romani L; Mencacci A; Cenci E; Spaccapelo R; Mosci P; Puccetti P; Bistoni F
    J Immunol; 1993 Feb; 150(3):925-31. PubMed ID: 8093707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The new immunosuppressants, the malononitrilamides MNA 279 and MNA 715, inhibit various graft-vs.-host diseases (GvHD) in rodents.
    Schorlemmer HU; Kurrle R; Bartlett RR
    Drugs Exp Clin Res; 1997; 23(5-6):167-73. PubMed ID: 9515226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of recombinant murine IL-12 and IFN-gamma in the pathogenesis of a murine systemic Candida albicans infection.
    Lavigne LM; Schopf LR; Chung CL; Maylor R; Sypek JP
    J Immunol; 1998 Jan; 160(1):284-92. PubMed ID: 9551982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-organism model of host defense against infection: a novel immunotoxicologic approach to evaluate immunomodulatory drugs.
    Herzyk DJ; Ruggieri EV; Cunningham L; Polsky R; Herold C; Klinkner AM; Badger A; Kerns WD; Bugelski PJ
    Toxicol Pathol; 1997; 25(4):351-62. PubMed ID: 9280118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of BCG-activated macrophages on the B-16 melanoma.
    Papilian-Todoruţiu C; Rişcă R; Mulea R; Daicoviciu D
    Rom J Morphol Embryol; 1990; 36(2):129-34. PubMed ID: 2149421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Mouse Model of Candidiasis.
    Fajardo P; Cuenda A; Sanz-Ezquerro JJ
    Methods Mol Biol; 2021; 2321():63-74. PubMed ID: 34048008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of the cephalosporin derivative cefodizime on the immune system in in vivo experiments].
    Hänel H
    Immun Infekt; 1986 Feb; 14(1):24-5. PubMed ID: 3957404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunotropic activity of human alpha1-glucoprotein].
    Liutov AG; Sadykov RF; Sibiriakh SV; Khaĭbullina SF; Aleshkin VA
    Patol Fiziol Eksp Ter; 1992; (1):37-9. PubMed ID: 1625929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Experimental studies in animals on the influence of fluocortin butylester on the course of generalized infections (author's transl)].
    Kessler HJ; Haude D; Okon C; Schumann P
    Arzneimittelforschung; 1977; 27(11a):2214-6. PubMed ID: 341900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of nucleotide restriction and supplementation on resistance to experimental murine candidiasis.
    Fanslow WC; Kulkarni AD; Van Buren CT; Rudolph FB
    JPEN J Parenter Enteral Nutr; 1988; 12(1):49-52. PubMed ID: 3278158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of antitumor effects of amphotericin B.
    Blanke T; Lynch R; Little JR
    Surg Forum; 1975; 26():126-8. PubMed ID: 2984
    [No Abstract]   [Full Text] [Related]  

  • 35. Involvement of host macrophages in the immunoadjuvant activity of amphotericin B in a mouse fungal infection model.
    Vecchiarelli A; Verducci G; Perito S; Puccetti P; Marconi P; Bistoni F
    J Antibiot (Tokyo); 1986 Jun; 39(6):846-55. PubMed ID: 3733533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunorestorative properties of ST 789 on experimentally immunosuppressed and infected mice.
    Foresta P; Riccardi C; Martelli EA
    Thymus; 1992; 19 Suppl 1():S97-107. PubMed ID: 1585424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Influence of amphotericin B on immunological response].
    Kato A; Nakagawa H; Fujita H
    Tsurumi Shigaku; 1978 Jun; 4(1):1-5. PubMed ID: 44579
    [No Abstract]   [Full Text] [Related]  

  • 38. Plasmid DNA modulates chronic graft-versus-host reaction.
    Vlasov VV; Rykova EY; Safronova IV; Lactionov PP; Kudaeva OT; Kozlov VA
    Dokl Biol Sci; 2002; 382():75-7. PubMed ID: 12004888
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunostimulatory properties of ethylene-2,2' -bis(dithio)bis(ethanol) and related compounds in vivo.
    Hiestand PC; Strasser M
    Int J Immunopharmacol; 1985; 7(1):141-51. PubMed ID: 3888866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Murine candidiasis: strain dependence of host responses after immunization.
    Ashman RB; Papadimitriou JM
    Immunol Cell Biol; 1988 Jan; 66 ( Pt 3)():231-7. PubMed ID: 3155159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 336.